Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/7/16 → 01/6/17 |
Funding
- Covance: $5,300.00
Incyte: A Randomized, Double-Blind Phase 1/2 Study of INCB039110 in Combination with Erlotinib Versus Erlotinib Alone in Subjects with Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Whose Tumors Have Epidermal Growth Factor
- Keresztes, Roger (PI)
- Kudelka, Andrzej (CoPI)
Project: Research